Global Brain Imaging Devices Market Expected to Expand at ~6% CAGR Through 2032 | DelveInsight
DelveInsight’s Brain Imaging Devices Market Insights report offers a comprehensive evaluation of current and future market trends, including market share analysis of leading companies, key growth drivers, barriers, challenges, and emerging opportunities shaping the competitive landscape.
The brain imaging devices market is witnessing notable expansion, driven by the rising burden of neurological disorders such as brain tumors, stroke, Alzheimer’s disease, Parkinson’s disease, and epilepsy. This growth is largely influenced by aging demographics and lifestyle-related risk factors. Moreover, continuous technological progress, especially the integration of artificial intelligence (AI) and machine learning, is enhancing imaging accuracy, accelerating diagnostic processes, and enabling more precise and personalized treatment strategies.
Get a sneak peek at the brain imaging devices market dynamics @ Brain Imaging Devices Market Trends
Brain Imaging Devices Market Overview
- The global brain imaging devices market is anticipated to grow significantly, increasing from approximately USD 5 billion in 2024 to nearly USD 7.7 billion by 2032, demonstrating sustained expansion.
- During the forecast period from 2025 to 2032, the market is projected to grow at a compound annual growth rate (CAGR) of around 6%.
- Key players operating in the brain imaging devices market include Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi High-Tech Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Esaote SPA, Mediso Ltd., Samsung Electronics Co., Ltd., MinFound Medical Systems Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Voxelgrids Innovations Private Limited, MR Solutions, PerkinElmer, Inc., Kindsway Biotech, SCHILLER, Neusoft Medical Systems Co., Ltd., Time Medical Holding, Koning Health, among others.
- Regionally, North America is expected to witness the highest growth rate throughout the forecast timeline.
- Within the product segmentation, magnetic resonance imaging (MRI) systems held the dominant market share in 2024.
To explore additional highlights and detailed insights, refer to the Global Brain Imaging Devices Market Forecast Report.
What Are the Key Drivers Fueling Brain Imaging Devices Market Growth?
Increasing Burden of Neurological Disorders
The growing global incidence of neurological diseases such as Alzheimer’s, Parkinson’s, stroke, epilepsy, and brain tumors has intensified the need for advanced imaging solutions. Early detection and continuous monitoring are essential for effective disease management, thereby increasing the adoption of imaging technologies like MRI, CT, and PET.
Advancements in Imaging Technologies
Ongoing innovations in imaging systems, including high-resolution MRI, functional MRI (fMRI), PET-CT hybrid imaging, and AI-enabled diagnostic tools, have significantly improved diagnostic capabilities. These advancements enhance image clarity, reduce scanning time, and enable accurate identification of neurological abnormalities, supporting market growth.
Expansion of Healthcare Infrastructure and Investments
Rising investments in healthcare infrastructure, particularly across developed regions such as North America and Europe, are improving access to advanced diagnostic equipment. Hospitals, imaging centers, and research facilities are increasingly adopting cutting-edge imaging technologies to address growing patient needs.
Growing Awareness and Emphasis on Early Diagnosis
Government initiatives, healthcare organizations, and non-profit entities are actively promoting early detection of neurological disorders. Increased awareness campaigns, preventive healthcare strategies, and routine screenings are encouraging the use of brain imaging technologies, thereby boosting market demand.
Adoption of Artificial Intelligence and Machine Learning
The incorporation of AI and machine learning into imaging systems is transforming diagnostic workflows. These technologies assist in faster image interpretation, anomaly detection, and predictive analysis, improving both operational efficiency and diagnostic accuracy, making imaging solutions more valuable to healthcare providers.
Rising Role of R&D and Clinical Trials
Pharmaceutical and medical device companies are increasingly utilizing advanced brain imaging tools in clinical research and drug development. Their application in neurological clinical trials is further contributing to the widespread adoption of imaging technologies.
Brain Imaging Devices Regional Insights: Why Is North America Leading the Market?
North America is expected to dominate the brain imaging devices market, supported by several critical factors. These include a high prevalence of neurological disorders, substantial investments in research and development, well-established healthcare infrastructure, and continuous innovation by major industry players.
Additionally, increasing awareness regarding early disease diagnosis is further accelerating market expansion, strengthening the region’s leading position globally.
Apart from disease burden, rapid technological advancements and product launches are significantly contributing to market growth. For instance, in December 2024, Philips introduced its AI-enabled CT 5300 system in North America during RSNA 2024. This system integrates advanced hardware with AI-driven Smart Workflow solutions to enhance diagnostic precision, minimize scan time, and improve accessibility to high-quality imaging.
Key features of this system include accurate patient positioning for faster setup, optimized imaging for cardiac and neurological assessments, and high-quality imaging with reduced radiation exposure, making it ideal for advanced diagnostic applications.
Collectively, these factors are expected to drive substantial growth in the North American brain imaging devices market.
To know more about why North America is leading the market growth in the brain imaging devices market, get a snapshot of the Brain Imaging Devices Market Outlook
Recent Developments in the Brain Imaging Devices Market
- In February 2025, Wellumio, a New Zealand-based medical device company specializing in stroke detection technologies, announced the enrollment of the first patient in a study evaluating its portable MRI device, Axana. This study aims to assess the device’s safety, usability, and effectiveness in detecting acute stroke cases in emergency settings.
- In December 2024, Canon Medical Systems USA expanded its AI-based CT imaging portfolio with solutions such as INSTINX and Vitrea, designed to improve scanning efficiency and diagnostic accuracy.
- During RSNA 2024, Philips launched its CT 5300 system powered by AI-driven Smart Workflow technology to enhance diagnostic confidence, reduce scanning time, and increase imaging accessibility.
- In November 2024, GE HealthCare received FDA 510(k) clearance for its SIGNA™ MAGNUS, a specialized 3.0T MRI system focused on advanced neuroimaging and biomarker research.
- In March 2024, Fujifilm India introduced the Echelon Synergy 1.5T MRI system at the CT & MRI User Conclave in Mumbai, offering faster imaging, AI integration, improved energy efficiency, and enhanced patient comfort.
Brain Imaging Devices: Technology Overview
Brain imaging devices play a crucial role in modern diagnostics and neuroscience research by enabling detailed visualization of brain structure and function. These technologies include MRI, CT, PET, and EEG systems.
MRI is widely used due to its ability to produce high-resolution images of soft tissues, making it effective for detecting tumors, vascular conditions, and neurodegenerative diseases. CT scans are commonly utilized for rapid assessment of brain injuries, strokes, and hemorrhages. PET imaging provides insights into metabolic and functional processes, aiding in the diagnosis of conditions like Alzheimer’s disease and epilepsy. EEG, on the other hand, measures electrical activity in the brain and is particularly useful for identifying seizures and sleep-related disorders.
Together, these imaging modalities offer a comprehensive approach to diagnosing and studying neurological conditions.
Brain Imaging Devices Market Report Highlights
- Market coverage: Global
- Study period: 2022–2032
- CAGR: Approximately 6%
- Market size by 2032: USD 7.7 billion
Brain Imaging Devices Market Segmentation Overview
The brain imaging devices market is segmented based on:
- Product Type: MRI, CT/SPECT, PET, and others, along with accessories and consumables
- Portability: Stationary and portable devices
- Application: Stroke, brain tumors, epilepsy, and others
- End Users: Hospitals, diagnostic imaging centers, and research institutions
- Geography: North America, Europe, Asia-Pacific, and Rest of the World
The report also includes detailed analysis using Porter’s Five Forces, company profiles, case studies, key opinion leader (KOL) insights, and expert analyst perspectives.
Interested in knowing the brain imaging devices market by 2032? Click to get a snapshot of the Brain Imaging Devices Market Assessment
Table of Contents
- Brain Imaging Devices Market Report Introduction
- Brain Imaging Devices Market Executive Summary
- Competitive Landscape
- Regulatory Analysis
- Brain Imaging Devices Market Key Factors Analysis
- Brain Imaging Devices Market Porter’s Five Forces Analysis
- Brain Imaging Devices Market Layout
- Brain Imaging Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
Conclusion
The brain imaging devices market is set for steady growth through 2032, driven by increasing neurological disease burden, technological advancements, expanding healthcare infrastructure, and rising awareness of early diagnosis. Continuous innovation and integration of AI-based solutions are expected to further enhance the capabilities and adoption of these devices globally.
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
